Takeda Oncology Revenue and Competitors
Estimated Revenue & Valuation
- Takeda Oncology's estimated annual revenue is currently $434.6M per year.
- Takeda Oncology's estimated revenue per employee is $201,000
Employee Data
- Takeda Oncology has 2162 Employees.
- Takeda Oncology grew their employee count by 1% last year.
Takeda Oncology's People
Name | Title | Email/Phone |
---|---|---|
1 | VP | Reveal Email/Phone |
2 | Chief Staff, GMAO | Reveal Email/Phone |
3 | Head Evidence Generation, Global Medical Affairs | Reveal Email/Phone |
4 | Head U.S. Strategy & Operations | Reveal Email/Phone |
5 | Head Patient Advocacy & Engagement | Reveal Email/Phone |
6 | Head US Insights & Analytics | Reveal Email/Phone |
7 | Head US Oncology Pricing, Contracting & Health Economics | Reveal Email/Phone |
8 | Associate Director, Global Program Management, Pediatric Programs | Reveal Email/Phone |
9 | Chief Counsel & Chief Compliance Officer | Reveal Email/Phone |
10 | Sr. Director ODDU, Head Cold-to-Hot Biology | Reveal Email/Phone |
Takeda Oncology Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1459.1M | 3860 | 6% | N/A | N/A |
What Is Takeda Oncology?
Millennium: The Takeda Oncology Company combines the innovative science of a leading American biopharmaceutical company with the global assets – both intellectual and fiscal – of Japan's largest pharmaceutical company.
keywords:N/AN/A
Total Funding
2162
Number of Employees
$434.6M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Takeda Oncology News
In early studies of two therapies presented at the annual meeting of the American Association for Cancer Research, researchers at Presage and Takeda showed that...
With the launch of its new niche lung cancer drug Exkivity in September last year and a slew of precision cancer meds in the pipeline, Takeda Oncology is...
Japanese pharmaceutical company Takeda announced on Friday that Brigatinib, an innovative lung cancer drug, has been approved by China's...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $821.8M | 2174 | 9% | N/A |
#2 | $964.6M | 2237 | N/A | N/A |
#3 | $555.5M | 2240 | -4% | $96.5M |
#4 | $477.5M | 2436 | 34% | N/A |
#5 | $481.1M | 2658 | N/A | N/A |